A Quick Word on Coverage in 2026 Insurance for weight-loss medication is still a moving target
Ocular Very common (10% or more): Diabetic retinopathy (up to 20.1%) Common (1% to 10%): Retinal disorders, diabetic retinopathy complications Uncommon (0.1% to 1%): Nonproliferative retinopathy Very rare (less than 0.01%): Nonarteritic anterior ischemic optic neuropathy (NAION) Diabetic retinopathy complications included need for retinal photocoagulation, need for treatment with intravitreal agents, vitreous hemorrhage, and onset of diabetes-related blindness
Context matters enormously here
Does the FDA approve compounded semaglutide the way it approves branded drugs
And then you know, find community find folks that are going through the same thing that you are and talk honestly and openly with them
I always recommend talking to your healthcare provider before taking a new supplement if you have any medical conditions that require medication, or if youre pregnant (or planning to become pregnant), or nursing